15
Participants
Start Date
March 31, 2011
Primary Completion Date
May 31, 2011
Study Completion Date
May 31, 2011
warfarin
2 single 25 mg doses of Warfarin (5 x 5 mg tablets) administered 14 days apart
fostamatinib
2 x 50 mg Fostamatinib tablets (100 mg) twice daily for 13 days
Research Site, London
Lead Sponsor
AstraZeneca
INDUSTRY